ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

DCE Concepts Approved

June 27, 1986

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

February 2, 1996

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978